
Lot Reference
Z33-CP10
Bioactive Peptide
CJC-1295 + Ipamorelin Blend
A combination vial of CJC-1295 (no-DAC) and Ipamorelin, each at 5 mg. CJC-1295 acts at GHRH receptors while Ipamorelin selectively activates the ghrelin/GHS receptor; together they generate dual-pathway amplification of endogenous growth-hormone pulsatility without significant cortisol or prolactin elevation in research literature.
Volume tier — qty 5+: −10% applied at checkout
Specification sheet
- Identity
- Mass-spec confirmed
- Purity (HPLC)
- ≥99.0%
- Endotoxin
- <0.25 EU/mg
- Storage
- −20°C, sealed
- Form
- Lyophilized powder
- Solvent (recom.)
- 0.6% acetic acid
CoA per lot
Verified ID
Identity confirmed to 4 decimal-place mass
Cold-chain
Vacuum-sealed, temperature-monitored
Use
Research use only · non-human
Shipping
Standard · 5–7 days · flat $10
Return policy
Open-vial exempt · sealed within 30d